Ecology of the Oral Microbiome: Beyond Bacteria

Trends in Microbiology

Volumn 25, Issue 5, 2017, Pages 362-374

  Baker, Jonathon L ^a   Bor, Batbileg ^a   Agnello, Melissa ^a   Shi, Wenyuan ^a,b   He, Xuesong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b C3 Jian Inc   (United States)

Author keywords

Candidate phyla radiation; Fungi; Meta omics; Oral microbiome; Phage

Indexed keywords

INTERNAL TRANSCRIBED SPACER; RIBOSOME RNA; RNA 16S;

BACTERIOPHAGE; CANDIDA ALBICANS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; COMMUNITY STRUCTURE; DYSBIOSIS; ECOLOGY; FUSOBACTERIUM NUCLEATUM; HOLISTIC CARE; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIOME; MOUTH CAVITY; NEXT GENERATION SEQUENCING; NONHUMAN; REVIEW; RNA SEQUENCE; STREPTOCOCCUS MUTANS; STREPTOCOCCUS ORALIS; BACTERIUM; BIODIVERSITY; FUNGUS; GENETICS; HUMAN; METABOLISM; METAGENOME; MICROBIOLOGY; MICROFLORA; MOUTH; VIRUS;

BACTERIA; BACTERIOPHAGES; BIODIVERSITY; FUNGI; HUMANS; METAGENOME; MICROBIOTA; MOUTH; VIRUSES;

EID: 85009471289     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2016.12.012     Document Type: Review

References (104)

1. 1 Gest, H., The discovery of microorganisms by Robert Hooke and Antoni Van Leeuwenhoek, fellows of the Royal Society. Notes Rec. R. Soc. Lond. 58 (2004), 187–201.
2. 2 Kuramitsu, H.K., Interspecies interactions within oral microbial communities. Microbiol. Mol. Biol. Rev. 71 (2007), 653–670.
3. 3 Kolenbrander, P.E., Oral microbial communities: biofilms, interactions, and genetic systems. Annu. Rev. Microbiol. 54 (2000), 413–437.
4. 4 Kolenbrander, P.E., et al. Oral multispecies biofilm development and the key role of cell–cell distance. Nat. Rev. Microbiol. 8 (2010), 471–480.
5. 5 Belstrom, D., Temporal stability of the salivary microbiota in oral health. PLoS One, 11, 2016, e0147472.
6. 6 He, X., The social structure of microbial community involved in colonization resistance. ISME J. 8 (2014), 564–574.
7. 7 Hug, L.A., A new view of the tree of life. Nat. Microbiol., 1, 2016, 16048.
8. 8 Guo, L., Intercellular communications in multispecies oral microbial communities. Front. Microbiol., 5, 2014, 328.
9. 9 Edlund, A., An in vitro biofilm model system maintaining a highly reproducible species and metabolic diversity approaching that of the human oral microbiome. Microbiome, 1, 2013, 25.
10. 10 Edlund, A., Meta-omics uncover temporal regulation of pathways across oral microbiome genera during in vitro sugar metabolism. ISME J., 9, 2015 2605–2519.
11. 11 Dewhirst, F.E., The human oral microbiome. J. Bacteriol. 192 (2010), 5002–5017.
12. 12 Cui, L., The human mycobiome in health and disease. Genome Med., 5, 2013, 63.
13. 13 Delhaes, L., The airway microbiota in cystic fibrosis: a complex fungal and bacterial community – implications for therapeutic management. PLoS One, 7, 2012, e36313.
14. 14 Seed, P.C., The human mycobiome. Cold Spring Harb. Perspect. Med., 5, 2015, a019810.
15. 15 Rizzetto, L., Richness and diversity of mammalian fungal communities shape innate and adaptive immunity in health and disease. Eur. J. Immunol. 44 (2014), 3166–3181.
16. 16 Nguyen, L.D., The lung mycobiome: an emerging field of the human respiratory microbiome. Front. Microbiol., 6, 2015, 89.
17. 17 Abeles, S.R., Pride, D.T., Molecular bases and role of viruses in the human microbiome. J. Mol. Biol. 426 (2014), 3892–3906.
18. 18 Pride, D.T., Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome. ISME J. 6 (2012), 915–926.
19. 19 Ly, M., et al. Altered oral viral ecology in association with periodontal disease. mBio 5 (2014), 01133–1214.
20. 20 Breitbart, M., Rohwer, F., Method for discovering novel DNA viruses in blood using viral particle selection and shotgun sequencing. Biotechniques 39 (2005), 729–736.
21. 21 Lecuit, M., Eloit, M., The human virome: new tools and concepts. Trends Microbiol. 21 (2013), 510–515.
22. 22 Bikel, S., Combining metagenomics, metatranscriptomics and viromics to explore novel microbial interactions: towards a systems-level understanding of human microbiome. Comput. Struct. Biotechnol. J. 13 (2015), 390–401.
23. 23 Edwards, R.A., Computational approaches to predict bacteriophage-host relationships. FEMS Microbiol. Rev. 40 (2016), 258–272.
24. 24 Ogilvie, L.A., Jones, B.V., The human gut virome: a multifaceted majority. Front. Microbiol., 6, 2015, 918.
25. 25 Mukherjee, P.K., Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi. PLoS Pathog., 10, 2014, e1003996.
26. 26 Norman, J.M., Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160 (2015), 447–460.
27. 27 Mark Welch, J.L., Biogeography of a human oral microbiome at the micron scale. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), E791–E800.
28. 28 Oh, J., Temporal stability of the human skin microbiome. Cell 165 (2016), 854–866.
29. 29 Zhang, X., The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 21 (2015), 895–905.
30. 30 Yost, S., Functional signatures of oral dysbiosis during periodontitis progression revealed by microbial metatranscriptome analysis. Genome Med., 7, 2015, 27.
31. 31 Jorth, P., et al. Metatranscriptomics of the human oral microbiome during health and disease. mBio 5 (2014), e01012–e01014.
32. 32 He, X., Cultivation of a human-associated TM7 phylotype reveals a reduced genome and epibiotic parasitic lifestyle. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 244–249.
33. 33 Brown, C.T., Unusual biology across a group comprising more than 15% of domain Bacteria. Nature 523 (2015), 208–211.
34. 34 Attar, N., Bacterial evolution: CPR breathes new air into the tree of life. Nat. Rev. Microbiol. 14 (2016), 332–333.
35. 35 Wrighton, K.C., RubisCO of a nucleoside pathway known from Archaea is found in diverse uncultivated phyla in bacteria. ISME J. 10 (2016), 2702–2714.
36. 36 Burstein, D., Major bacterial lineages are essentially devoid of CRISPR-Cas viral defence systems. Nat. Commun., 7, 2016, 10613.
37. 37 Campbell, J.H., UGA is an additional glycine codon in uncultured SR1 bacteria from the human microbiota. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 5540–5545.
38. 38 Rinke, C., Insights into the phylogeny and coding potential of microbial dark matter. Nature 499 (2013), 431–437.
39. 39 Luef, B., Diverse uncultivated ultra-small bacterial cells in groundwater. Nat. Commun., 6, 2015, 6372.
40. 40 Solden, L., The bright side of microbial dark matter: lessons learned from the uncultivated majority. Curr. Opin. Microbiol. 31 (2016), 217–226.
41. 41 Segata, N., Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol., 13, 2012, R42.
42. 42 Zhou, Y., Biogeography of the ecosystems of the healthy human body. Genome Biol., 14, 2013, R1.
43. 43 Fredricks, D.N., Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 353 (2005), 1899–1911.
44. 44 Soro, V., Axenic culture of a candidate division TM7 bacterium from the human oral cavity and biofilm interactions with other oral bacteria. Appl. Environ. Microbiol. 80 (2014), 6480–6489.
45. 45 Kianoush, N., Bacterial profile of dentine caries and the impact of pH on bacterial population diversity. PLoS One, 9, 2014, e92940.
46. 46 Kuehbacher, T., Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease. J. Med. Microbiol. 57 (2008), 1569–1576.
47. 47 Paster, B.J., Bacterial diversity in human subgingival plaque. J. Bacteriol. 183 (2001), 3770–3783.
48. 48 Brinig, M.M., Prevalence of bacteria of division TM7 in human subgingival plaque and their association with disease. Appl. Environ. Microbiol. 69 (2003), 1687–1694.
49. 49 Rylev, M., Microbiological and immunological characteristics of young Moroccan patients with aggressive periodontitis with and without detectable Aggregatibacter actinomycetemcomitans JP2 infection. Mol. Oral. Microbiol. 26 (2011), 35–51.
50. 50 Liu, B., Deep sequencing of the oral microbiome reveals signatures of periodontal disease. PLoS One, 7, 2012, e37919.
51. 51 Griffen, A.L., Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J. 6 (2012), 1176–1185.
52. 52 Takeshita, T., Discrimination of the oral microbiota associated with high hydrogen sulfide and methyl mercaptan production. Sci. Rep., 2, 2012, 215.
53. 53 McLean, J.S., et al. Draft genome sequence of Actinomyces odontolyticus subsp. actinosynbacter Strain XH001, the basibiont of an oral TM7 epibiont. Genome Announc., 4(1), 2016 e01685-15.
54. 54 Bor, B., Morphological and physiological changes induced by contact-dependent interaction between Candida albicans and Fusobacterium nucleatum. Sci. Rep., 6, 2016, 27956.
55. 55 Camanocha, A., Dewhirst, F.E., Host-associated bacterial taxa from Chlorobi, Chloroflexi, GN02, Synergistetes, SR1, TM7, and WPS-2 Phyla/candidate divisions. J. Oral. Microbiol., 6, 2014, 25468.
56. 56 Abusleme, L., The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J. 7 (2013), 1016–1025.
57. 57 Costalonga, M., Herzberg, M.C., The oral microbiome and the immunobiology of periodontal disease and caries. Immunol. Lett. 162 (2014), 22–38.
58. 58 Ghannoum, M.A., Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog., 6, 2010, e1000713.
59. 59 Dupuy, A.K., Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensal. PLoS One, 9, 2014, e90899.
60. 60 Underhill, D.M., Iliev, I.D., The mycobiota: interactions between commensal fungi and the host immune system. Nat. Rev. Immunol. 14 (2014), 405–416.
61. 61 Oever, J.T., Netea, M.G., The bacteriome-mycobiome interaction and antifungal host defense. Eur. J. Immunol. 44 (2014), 3182–3191.
62. 62 Janus, M.M., Candida albicans in multispecies oral communities; a keystone commensal?. Adv. Exp. Med. Biol. 931 (2016), 13–20.
63. 63 Diaz, P.I., et al. Fungal–bacterial interactions and their relevance to oral health: linking the clinic and the bench. Front. Cell. Infect. Microbiol., 4, 2014, 101.
64. 64 Allison, D.L., et al. Candida–bacteria interactions: their impact on human disease. Microbiol. Spectr., 2016, 10.1128/microbiolspec Published online June, 2016.
65. 65 Abeles, S.R., Human oral viruses are personal, persistent and gender-consistent. ISME J. 8 (2014), 1753–1767.
66. 66 Robles-Sikisaka, R., Association between living environment and human oral viral ecology. ISME J. 7 (2013), 1710–1724.
67. 67 Abeles, S.R., Effects of long term antibiotic therapy on human oral and fecal viromes. PLoS One, 10, 2015, e0134941.
68. 68 Wylie, K.M., Metagenomic analysis of double-stranded DNA viruses in healthy adults. BMC Biol., 12, 2014, 71.
69. 69 Naidu, M., Characterization of bacteriophage communities and CRISPR profiles from dental plaque. BMC Microbiol., 14, 2014, 175.
70. 70 Stein, J.M., Failure to detect an association between aggressive periodontitis and the prevalence of herpesviruses. J. Clin. Periodontol. 40 (2013), 1–7.
71. 71 Roberts, A.P., Kreth, J., The impact of horizontal gene transfer on the adaptive ability of the human oral microbiome. Front. Cell. Infect. Microbiol., 4, 2014, 124.
72. 72 Lugli, G.A., Prophages of the genus Bifidobacterium as modulating agents of the infant gut microbiota. Environ. Microbiol. 18 (2016), 2196–2213.
73. 73 Manrique, P., Healthy human gut phageome. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 10400–10405.
74. 74 Debarbieux, L., Bacterial sensing of bacteriophages in communities: the search for the Rosetta stone. Curr. Opin. Microbiol. 20 (2014), 125–130.
75. 75 De Paepe, M., Bacteriophages: an underestimated role in human and animal health?. Front. Cell. Infect. Microbiol., 4, 2014, 39.
76. 76 Mills, S., Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes 4 (2013), 4–16.
77. 77 Zhou, H., CRISPRs provide broad and robust protection to oral microbial flora of gingival health against bacteriophage challenge. Protein Cell 6 (2015), 541–545.
78. 78 Lum, A.G., Global transcription of CRISPR loci in the human oral cavity. BMC Genomics, 16, 2015, 401.
79. 79 Pawluk, A., Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species. Nat. Microbiol., 1, 2016, 16085.
80. 80 Maxwell, K.L., Phages fight back: inactivation of the CRISPR-Cas bacterial immune system by anti-CRISPR proteins. PLoS Pathog., 12, 2016, e1005282.
81. 81 Wahida, A., The Janus-Face of bacteriophages across human body habitats. PLoS Pathog., 12, 2016, e1005634.
82. 82 Betts, A., Back to the future: evolving bacteriophages to increase their effectiveness against the pathogen Pseudomonas aeruginosa PAO1. Evol. Appl. 6 (2013), 1054–1063.
83. 83 Torres-Barcelo, C., Hochberg, M.E., Evolutionary rationale for phages as complements of antibiotics. Trends Microbiol. 24 (2016), 249–256.
84. 84 Abedon, S.T., Ecology of anti-biofilm agents II: bacteriophage exploitation and biocontrol of biofilm bacteria. Pharmaceuticals (Basel) 8 (2015), 559–589.
85. 85 Young, R., Gill, J.J., Microbiology. Phage therapy redux – what is to be done?. Science 350 (2015), 1163–1164.
86. 86 Machuca, P., Isolation of a novel bacteriophage specific for the periodontal pathogen Fusobacterium nucleatum. Appl. Environ. Microbiol. 76 (2010), 7243–7250.
87. 87 Aljarbou, A.N., Aljofan, M., Genotyping, morphology and molecular characteristics of a lytic phage of Neisseria strain obtained from infected human dental plaque. J. Microbiol. 52 (2014), 609–618.
88. 88 Dalmasso, M., Isolation of a novel phage with activity against Streptococcus mutans biofilms. PLoS One, 10, 2015, e0138651.
89. 89 Bor, B., Phenotypic and physiological characterization of the epibiotic interaction between TM7x and its basibiont Actinomyces. Microb. Ecol. 71 (2016), 243–255.
90. 90 Shirtliff, M.E., Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol. Lett. 299 (2009), 1–8.
91. 91 Krom, B.P., Candida and other fungal species: forgotten players of healthy oral microbiota. J. Dent. Res. 93 (2014), 445–451.
92. 92 Xu, H., et al. Innocent until proven guilty: mechanisms and roles of Streptococcus-Candida interactions in oral health and disease. Mol. Oral Microbiol. 29 (2014), 99–116.
93. 93 Wright, C.J., Microbial interactions in building of communities. Mol. Oral Microbiol. 28 (2013), 83–101.
94. 94 Cavalcanti, I.M., et al. Interactions between Streptococcus oralis, Actinomyces oris, and Candida albicans in the development of multispecies oral microbial biofilms on salivary pellicle. Mol. Oral Microbiol., 2016, 10.1111/omi.12154 Published online March 15, 2016.
95. 95 Cavalcanti, I.M., Interkingdom cooperation between Candida albicans, Streptococcus oralis and Actinomyces oris modulates early biofilm development on denture material. Pathog. Dis., 74, 2016, ftw002.
96. 96 Xu, H., Streptococcus oralis and Candida albicans synergistically activate mu-calpain to degrade E-cadherin from oral epithelial junctions. J. Infect. Dis. 214 (2016), 925–934.
97. 97 Diaz, P.I., et al. Synergistic interaction between Candida albicans and commensal oral streptococci in a novel in vitro mucosal model. Infect. Immun. 80 (2012), 620–632.
98. 98 Falsetta, M.L., Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo. Infect. Immun. 82 (2014), 1968–1981.
99. 99 Willems, H.M., Candida albicans in oral biofilms could prevent caries. Pathog. Dis., 74, 2016, ftw039.
100. 100 Arzmi, M.H., et al. Polymicrobial biofilm formation by Candida albicans, Actinomyces naeslundii, and Streptococcus mutans is Candida albicans strain and medium dependent. Med. Mycol. 54 (2016), 856–864.
101. 101 Sztajer, H., Cross-feeding and interkingdom communication in dual-species biofilms of Streptococcus mutans and Candida albicans. ISME J. 8 (2014), 2256–2271.
102. 102 Hwang, G., binding force dynamics of Streptococcus mutans-glucosyltransferase B to Candida albicans. J. Dent. Res. 94 (2015), 1310–1317.
103. 103 Koo, H., Bowen, W.H., Candida albicans and Streptococcus mutans: a potential synergistic alliance to cause virulent tooth decay in children. Future Microbiol. 9 (2014), 1295–1297.
104. 104 Thomas, A., et al. Association of oral Candida albicans with severe early childhood caries – a pilot study. J. Clin. Diagn. Res. 10 (2016), ZC109–ZC112.